Clinical Trial Update: Role of Combination Therapy in Women With Refractory Overactive Bladder [NA]

View source ↗

Summary

A clinical trial investigating combination therapy for women with refractory overactive bladder has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Overactive Bladder Syndrome | NA | Status: WITHDRAWN